< Back to situations

Get alerts on this situation

We’ll email you as it develops, and you can follow the whole thread from day one.

Unsubscribe anytime.

[SITUATION] · [ACTIVE]

2 clusters · 7 sources · 1 days · First seen 3 days ago · Last updated 3 days ago

Categories: BUSINESS

US corporate earnings reports 2026

Entities: Meta Platforms · Dolby Laboratories · Dexcom Inc. · G8 continuous glucose monitor · Kevin Yeaman

Overview

Dexcom’s second‑quarter 2026 results beat expectations, with adjusted EPS of $0.70 versus $0.61 consensus and revenue of $1.31 billion, a 13.1% YoY rise. The company lifted its fiscal‑2026 revenue outlook to $5.18‑$5.25 billion, unveiled the next‑generation G8 CGM, secured FDA clearance for the Stelo over‑the‑counter CGM for children, and completed its Nutrisense acquisition. It repurchased roughly $600 million of its own stock and saw Avidity Partners add a 1.1% stake. The quarter generated net profit of $249.1 million, or $0.64 per share, and management highlighted strong international sales growth and an expanding margin outlook.

Dolby Laboratories reported fiscal Q3 2026 revenue of $305 million, down from the prior year, but posted GAAP net income of $29 million and non‑GAAP EPS of $0.69, beating estimates. The firm repurchased 1.2 million shares for about $65 million and raised full‑year guidance to $4.25‑$4.40 EPS and $1.41‑$1.44 billion revenue, with Q4 EPS projected at $1.13‑$1.28 and revenue $362‑$392 million. Management highlighted a large video‑distribution deal with Meta, expanded licensing with Alibaba, automotive partnerships (Volkswagen, Buick, Android Auto), new RayNeo AR glasses, Dolby Vision 2 TVs from Hisense, TCL and Philips, and the use of Dolby Atmos and Vision for the 2026 FIFA World Cup.

Claims

What the coverage asserts, and how well corroborated each claim is across sources.

[● 3 SOURCES] Dexcom Q2 revenue was $1.31 billion. (Dexcom Q2 earnings release)
[● 3 SOURCES] Dexcom reported EPS of $0.70 for the quarter, beating consensus $0.61. (Dexcom Q2 earnings release)
[● 3 SOURCES] Dolby reported total revenue of $305 million for fiscal Q3 2026. (Dolby Laboratories Q3 2026 financial results)
[● 3 SOURCES] Non‑GAAP net income for Q3 2026 was $65 million, or $0.69 per diluted share. (Dolby Laboratories Q3 2026 financial results)
[● 3 SOURCES] Dolby expects Q4 2026 EPS of $1.13‑$1.28 per share and revenue of $362‑$392 million. (Dolby Laboratories Q3 2026 financial results)
[● 2 SOURCES] Dexcom reported Q2 profit of $249.1 million, or 64¢ per share. (Dexcom Q2 earnings release)
[● 2 SOURCES] Dexcom received FDA clearance for its Stelo over‑the‑counter CGM for children. (Dexcom Q2 earnings release)
[● 2 SOURCES] Dexcom unveiled its next‑generation G8 continuous glucose monitor at Investor Day. (Dexcom Q2 earnings release)
[● 2 SOURCES] Dexcom raised its fiscal 2026 revenue guidance midpoint to $5.18‑$5.25 billion. (Dexcom Q2 earnings release)
[● 2 SOURCES] GAAP net income for Q3 2026 was $29 million, or $0.30 per diluted share. (Dolby Laboratories Q3 2026 financial results)
[● 2 SOURCES] Dolby repurchased 1.2 million shares for approximately $65 million. (Dolby Laboratories Q3 2026 financial results)
[● 2 SOURCES] Dolby raised its full‑year 2026 EPS guidance to $4.25‑$4.40 per share. (Dolby Laboratories Q3 2026 financial results)

Timeline

3 days ago

[BUSINESS] 6 sources
Dolby Laboratories posts Q3 2026 earnings, beats expectations and raises guidance
Dolby reported Q3 FY2026 revenue of $305 M, non‑GAAP EPS of $0.69 beating estimates, raised full‑year guidance and repurchased 1.2 M shares.
3 days ago

[BUSINESS] 3 sources
Dexcom posts Q2 earnings beat and lifts 2026 revenue outlook
Dexcom posted Q2 2026 earnings of $0.70 EPS on $1.31 B revenue, beat forecasts, raised 2026 revenue guidance to $5.18‑$5.25 B, unveiled G8 CGM, cleared Stelo CGM for kids, completed Nutrisense acquisition and $

Sources

digitalmedianet.com · drugdeliverybusiness.com · foreignpolicyjournal.com · liveblogwp.wtop.com · mommygearest.com · seekingalpha.com · stocknews.com

This summary has been updated 3 times: see revision history